Survival benefit with regorafenib and/or trifluridine/tipiracil sequencing to rechallenge with anti-EGFR-based third-line regimens in metastatic colorectal cancer: A multicenter retrospective real-world subgroups comparison

被引：0
|
作者：
Signorelli, Carlo
Chilelli, Mario Giovanni
Basso, Michele
Calegari, Maria Alessandra
Anghelone, Annunziato
Lucchetti, Jessica
Minelli, Alessandro
Angotti, Lorenzo
Zurlo, Ina Valeria
Schirripa, Marta
Morelli, Cristina
Dell'Aquila, Emanuela
Gemma, Donatello
Corsi, Domenico Cristiano
Arrivi, Giulia
Zoratto, Federica
Morandi, Maria Grazia
Santamaria, Fiorenza
Saltarelli, Rosa
Ruggeri, Enzo Maria
机构：
[1] ASL Viterbo, Belcolle Hosp, Med Oncol Unit, Viterbo, Italy
[2] IRCCS, Med Oncol Unit, Ctr Comprehens Canc, Fdn Policlin Univ Agostino Gemelli, Rome, Italy
[3] IRCCS, Oncol Med, Ctr Comprehens Canc, Fdn Policlin Univ Agostino Gemelli, Rome, Italy
[4] Policlin Univ Campus Biomed, Div Med Oncol, Rome, Italy
[5] Vito Fazzi Hosp, Lecce, Italy
[6] Tor Vergata Univ Hosp, Dept Syst Med, Med Oncol Unit, Rome, Italy
[7] IRCCS Regina Elena Natl Canc Inst, Rome, Italy
[8] ASL Frosinone, Med Oncol Unit, Sora, Fr, Italy
[9] Isola Tiberina Hosp Gemelli Isola, Med Oncol Unit, Rome, Italy
[10] Sapienza Univ Rome, St Andrea Univ Hosp, Dept Clin & Mol Med, Oncol Unit, Rome, Italy
[11] ASL Latina, UOC Oncol, Osped Santa Maria Goretti, Latina, Italy
[12] ASL Rieti, San Camillo Lellis Hosp, Med Oncol Unit, Rieti, Italy
[13] Sapienza Univ Rome, Dept Expt Med, Rome, Italy
[14] ASL RM5, UOC Oncol, San Giovanni Evangelista Hosp, Tivoli, Rm, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15553
引用
收藏
页数：1
相关论文
共 34 条
  • [1] Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study
    Signorelli, Carlo
    Calegari, Maria Alessandra
    Basso, Michele
    Anghelone, Annunziato
    Lucchetti, Jessica
    Minelli, Alessandro
    Angotti, Lorenzo
    Zurlo, Ina Valeria
    Schirripa, Marta
    Chilelli, Mario Giovanni
    Morelli, Cristina
    Dell'Aquila, Emanuela
    Cosimati, Antonella
    Gemma, Donatello
    Ribelli, Marta
    Emiliani, Alessandra
    Corsi, Domenico Cristiano
    Arrivi, Giulia
    Mazzuca, Federica
    Zoratto, Federica
    Morandi, Maria Grazia
    Santamaria, Fiorenza
    Saltarelli, Rosa
    Ruggeri, Enzo Maria
    CURRENT ONCOLOGY, 2023, 30 (06) : 5456 - 5469
  • [2] Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study
    Bazarbashi, Shouki
    Alkhatib, Radwan
    Aseafan, Mohamed
    Tuleimat, Yasmin
    Abdel-Aziz, Nashwa
    Mahrous, Mervat
    Elsamany, Sherif
    Elhassan, Tusneem
    Alghamdi, Mohammed
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [3] A real-world comparison of trifluridine/tipiracil and regorafenib in refractory metastatic colorectal cancer in the United States
    Nevala-Plagemann, Christopher Duane
    Ying, Jian
    Sama, Shashank
    Florou, Vaia
    Haaland, Benjamin
    Garrido-Laguna, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [4] A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States
    Nevala-Plagemann, Christopher
    Sama, Shashank
    Ying, Jian
    Shen, Jincheng
    Haaland, Benjamin
    Florou, Vaia
    Garrido-Laguna, Ignacio
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (03): : 257 - 264
  • [5] Sequential treatment with regorafenib and trifluridine/tipiracil in later-line refractory metastatic colorectal cancer: A real-world multicenter retrospective study.
    Signorelli, Carlo
    Schirripa, Marta
    Chilelli, Mario Giovanni
    Calegari, Maria Alessandra
    Basso, Michele
    Anghelone, Annunziato
    Lucchetti, Jessica
    Minelli, Alessandro
    Angotti, Lorenzo
    Gemma, Donatello
    Dell'Aquila, Emanuela
    Cosimati, Antonella
    Arrivi, Giulia
    Morelli, Cristina
    Corsi, Domenico Cristiano
    Saltarelli, Rosa
    Morandi, Maria Grazia
    Zoratto, Federica
    Santamaria, Fiorenza
    Ruggeri, Enzo Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 45 - 45
  • [6] Retrospective study of regorafenib and trifluridine/tipiracil efficacy as a third-line or later chemotherapy regimen for refractory metastatic colorectal cancer
    Tanaka, Akira
    Sadahiro, Sotaro
    Suzuki, Toshiyuki
    Okada, Kazutake
    Saito, Gota
    Miyakita, Hiroshi
    ONCOLOGY LETTERS, 2018, 16 (05) : 6589 - 6597
  • [7] Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients
    Salvatore, Lisa
    Bensi, Maria
    Vivolo, Raffaella
    Zurlo, Ina Valeria
    Dell'Aquila, Emanuela
    Grande, Roberta
    Anghelone, Annunziato
    Emiliani, Alessandra
    Citarella, Fabrizio
    Calegari, Maria Alessandra
    Ribelli, Marta
    Basso, Michele
    Pozzo, Carmelo
    Tortora, Giampaolo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [8] Predictive and prognostic impact of primary tumor location on sequential treatment with regorafenib and trifluridine/tipiracil at third line and beyond in metastatic colorectal cancer: A real-world multicenter retrospective analysis
    Signorelli, C.
    Calegari, M. A.
    Basso, M.
    Anghelone, A.
    Lucchetti, J.
    Minelli, A.
    Angotti, L.
    Zurlo, I. V.
    Schirripa, M.
    Chilelli, M. G.
    Morelli, C.
    Dell'Aquila, E.
    Gemma, D.
    Ribelli, M.
    Arrivi, G.
    Zoratto, F.
    Morandi, M. G.
    Santamaria, F.
    Saltarelli, R.
    Ruggeri, E. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S442 - S443
  • [9] Effectiveness and safety of regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A real-world multicenter retrospective study with focus on sequential treatment
    Signorelli, C.
    Schirripa, M.
    Chilelli, M. G.
    Calegari, M. A.
    Basso, M.
    Anghelone, A.
    Lucchetti, J.
    Minelli, A.
    Angotti, L.
    Morelli, C.
    Dell'Aquila, E.
    Cosimati, A.
    Gemma, D.
    Ribelli, M.
    Corsi, D. C.
    Arrivi, G.
    Zoratto, F.
    Morandi, M. G.
    Santamaria, F.
    Saltarelli, R.
    Ruggeri, E. M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S719 - S719
  • [10] Regorafenib Plus for third-line treatment in metastatic colorectal cancer: A real-world study
    Yisilamu, Patiguli
    Yao, Jiannan
    Ge, Yang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
1234